IRCT20200316046789N1
Completed
未知
Comparison of the effectiveness of hormone therapy alone with hormone therapy and platelet-rich plasma in the improvement of Asherman's syndrome after hysteroscopy in educational centers of Isfahan University of Medical Sciences
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Asherman syndrome.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of Asherman's syndrome
- •Age: 18 to 43 years old
- •Informed consent to participate in the study
Exclusion Criteria
- •Simultaneous infection of the uterus and vagina
- •Hemoglobin less than 11
- •Platelet less than 150,000
- •History of anticoagulant use
- •Dissatisfaction with entering the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric statesIRCT138809032766N1Tarbiat Maodares University150
Completed
Phase 2
Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermianon-obstructive azoospermia.Male infertilityIRCT201612069014N137Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences28
Recruiting
Phase 2
Comparison of suppressive hormonal therapy(LD tablet) with aspiration in regression of ovarian endometriomaEndometriosis of ovary.Endometriosis of ovaryIRCT201609105563N8Vice chancellor for Research,Tabriz University Of Medical Sciences50
Recruiting
Not Applicable
Retrospective study of the efficacy of hormonal therapy for advanced or recurrent low-grade endometrial stromal sarcomaunresectable advanced or recurrent low-grade endometrial stromal sarcomaJPRN-UMIN000050780Shizuoka Cancer Center40
Active, not recruiting
Not Applicable
Effect of hormone replacement therapy versus risedronate on fracture recurrence in postmenopausal women with hip fractureEndocrine, nutritional and metabolic diseaseKCT0005513Samsung Medical Center300